QIM
IMGN

Quantitative Investment Management’s Immunogen Inc IMGN Stock Holding History

Quantitative Investment Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-166,469
Closed -$451K – 858
2019
Q1 		$451K Buy
166,469
+101,469
+156% +$440K 0.03% 507
2018
Q4 		$312K Buy
+65,000
New +$394K 0.02% 445
2017
Q1 		– Sell
-267,300
Closed -$545K – 958
2016
Q4 		$545K Buy
267,300
+221,400
+482% +$444K 0.01% 691
2016
Q3 		$123K Sell
45,900
-149,500
-77% -$435K ﹤0.01% 640
2016
Q2 		$601K Buy
195,400
+174,700
+844% +$1.1M 0.03% 515
2016
Q1 		$176K Buy
+20,700
New +$175K 0.01% 711
2015
Q4 		– Sell
-28,800
Closed -$276K – 884
2015
Q3 		$276K Sell
28,800
-14,400
-33% -$211K 0.02% 555
2015
Q2 		$621K Buy
43,200
+31,000
+254% +$340K 0.09% 197
2015
Q1 		$109K Buy
+12,200
New +$88.4K 0.01% 586

Other funds holding IMGN

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Quantitative Investment Management's IMGN Position: Q2 2019 in Review

Quantitative Investment Management sold out of Immunogen Inc (IMGN) in Q2 2019, closing a stake of 166,469 shares — an estimated $451K sold.

Quantitative Investment Management first reported a position in IMGN in Q1 2015 and held it in 9 quarters. The position peaked at $621K in Q2 2015. 192 funds tracked by Wall St. Rank hold IMGN as of Q2 2019.

  • Quantitative Investment Management reported no remaining Immunogen Inc position as of Q2 2019 after selling out during the quarter.
  • Quantitative Investment Management sold 166,469 Immunogen Inc shares in Q2 2019, an estimated $451K.
  • Quantitative Investment Management first reported a position in Immunogen Inc in Q1 2015 and held it in 9 quarters.
  • Quantitative Investment Management's Immunogen Inc position peaked at $621K in Q2 2015.
  • 192 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2019.

Based on Quantitative Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.